Workflow
中国人寿(601628):持续加仓权益利润创新高,NBV增速超预期
CMS·2025-10-31 15:16

Investment Rating - The report maintains a "Strong Buy" investment rating for the company [3] Core Insights - The company's NBV (New Business Value) growth exceeded expectations, with a year-on-year increase of 41.8% in the first three quarters of 2025, significantly improving from previous quarters [6] - The net profit attributable to shareholders reached 167.804 billion, a year-on-year increase of 60.5%, with a quarterly growth of 91.5% in Q3 [6] - The company has increased its equity investments, resulting in a total investment return of 6.4%, up by 1.0 percentage points year-on-year [6] Financial Data and Valuation - Total revenue is projected to grow from 405.04 billion in 2023 to 776.173 billion by 2027, with a compound annual growth rate (CAGR) of approximately 12% [2] - Net profit is expected to rise from 51.184 billion in 2023 to 241.173 billion in 2027, reflecting a growth rate of 19% in the final year [2] - The company's PE ratio is forecasted to decrease from 24.51 in 2023 to 5.20 by 2027, indicating increasing profitability relative to its stock price [2] Performance Metrics - As of the end of Q3 2025, the company's total assets reached 72,829.82 billion, a 10.2% increase from the beginning of the year [6] - The return on equity (ROE) stands at 27.2%, indicating strong profitability relative to shareholder equity [3] - The company's net assets attributable to shareholders increased by 22.8% year-to-date, reaching 6,258.28 billion [6]